23 These symptoms can be severe in some patients, resulting in a pause of dose escalation, and if intolerable GI symptoms continue, a dose adjustment to the previous lower dose or a switch to an alternative GLP-1 RA should be considered
Even Kind, which produces some of the most popular GLP-1 patches in the world, does not disclose its manufacturer, although it does state that it is based in China and holds multiple industry certifications. Other GLP-1 patches, like those that pop up on Amazon, have absolutely no information about where they are manufactured
Multimodal care works best: pain specialists, physical therapy, cognitive approaches, medications for nerve pain, and inflammation control
it's prepared per individual prescription and isn't FDA-reviewed for safety, effectiveness, or quality Compounded tirzepatide uses the same active ingredient as Mounjaro and Zepbound but carries the same compounded medication qualification - not FDA-approved as a finished drug product STEP 1 trial (NEJM): 14.9% average body weight loss at 68 weeks with semaglutide 2.4mg - this was the studied FDA-approved formulation in a controlled trial setting